Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus-Reference-Cited by-同舟云学术

Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus

Published:2023-01 Issue: Volume:209 Page:105474
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Parsons Andrea J.,Ophir Sabrina I.,Gardner Thomas J.,Paredes Jailene Casado,Stein Kathryn R.,Kwasny Steven M.,Cardinale Steven C.,Torhan Matthew,Prichard Mark N.,James Scott H.,Atanasoff Kristina E.,G-Dayanandan Narendran,Bowlin Terry L.,Opperman Timothy J.,Tortorella Domenico^ORCID

Funder

National Institutes of Health

U.S. Department of Health and Human Services

National Institute on Aging

National Institute of Allergy and Infectious Diseases

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference53 articles.

1. Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis;Adane;J. Int. Med. Res.,2021

2. Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers;Arav-Boger;PLoS One,2010

3. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays;Baell;J. Med. Chem.,2010

4. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates;Bevan;Anal. Chem.,2000

5. Thiourea inhibitors of herpes viruses. Part 1: bis-(aryl)thiourea inhibitors of CMV;Bloom;Bioorg. Med. Chem. Lett,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency;Archives of Virology;2024-07-06